IX Stock Analysis: Orix Ads | NYSE

Financial Conglomerates | NYSE, USA | Market Cap: 38.604m USD | 12M Return: 45.1% | US6863301015 | Charts, Fundamentals & Technical Analysis

Leasing, Real Estate, Insurance, Asset Management
Total Rating 55
Safety 73
Buy Signal -0.20
Financial Conglomerates
Industry Rotation: -5.8
Market Cap: 38.6B
Avg Turnover: 12.7M
Risk 3d forecast
Volatility23.9%
VaR 5th Pctl4.05%
VaR vs Median3.11%
Reward TTM
Sharpe Ratio1.28
Rel. Str. IBD75.2
Rel. Str. Peer Group29.2
Character TTM
Beta0.837
Beta Downside0.761
Hurst Exponent0.520
Drawdowns 3y
Max DD24.34%
CAGR/Max DD1.22
CAGR/Mean DD4.85
EPS (Earnings per Share) EPS (Earnings per Share) of IX over the last years for every Quarter: "2021-09": 2.97, "2021-12": 2.34, "2022-03": 3.26, "2022-06": 1.95, "2022-09": 1.74, "2022-12": 2.9, "2023-03": 1.94, "2023-06": 1.89, "2023-09": 1.86, "2023-12": 2.64, "2024-03": 3.6931, "2024-06": 2.4155, "2024-09": 0.55, "2024-12": 0.51, "2025-03": 2.42, "2025-06": 0.65, "2025-09": 0.9864, "2025-12": 0.6911, "2026-03": 0.3341, "2026-06": 1.57,
EPS CAGR: -36.09%
EPS Trend: -89.3%
Qual. Beats: 0
Revenue Revenue of IX over the last years for every Quarter: 2021-09: 632721, 2021-12: 626579, 2022-03: 652252, 2022-06: 657813, 2022-09: 707003, 2022-12: 630028, 2023-03: 668815, 2023-06: 676974, 2023-09: 682982, 2023-12: 678125, 2024-03: 776501, 2024-06: 708139, 2024-09: 695494, 2024-12: 750851, 2025-03: 720337, 2025-06: 768641, 2025-09: 795856, 2025-12: 840322, 2026-03: 938857.698, 2026-06: 876628,
Rev. CAGR: 8.58%
Rev. Trend: 94.5%
Last SUE: -0.07
Qual. Beats: 0

Warnings

Below Avwap Earnings

Tailwinds

No distinct edge detected

Seasonality 11.7 years of data

Jan +0.1% 7
Feb -2.9% 19
Mar +2.9% 6
Apr -2.1% 30
May +1.7% 31
Jun -4.8% 33
Jul +2.3% 23
Aug +0.6% 5
Sep +2.6% 25
Oct +0.4% 11
Nov +1.4% 14
Dec -1.2% 25

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: IX Orix Ads

ORIX Corporation (NYSE: IX) is a Japan-based diversified financial services group operating across ten business segments, including Corporate Financial Services and Maintenance Leasing, Real Estate, Private Equity Investment and Concession, Environment and Energy, Insurance, Banking and Credit, Aircraft and Ships, ORIX USA, ORIX Europe, and Asia and Australia. Its activities span auto and equipment leasing, real estate development and asset management, private equity, renewable energy and waste services, life insurance distribution through agents and digital channels, consumer finance, and aircraft and maritime investment and brokerage. The company also runs international operations through dedicated regional units in the U.S., Europe, and Asia-Pacific, offering asset management, advisory, and investment services. Originally incorporated in 1950 as Orient Leasing Co., Ltd., it adopted the ORIX name in 1989 and is headquartered in Minato, Japan.

As a large-cap diversified financials company, ORIX is part of a category of Japanese non-bank financial groups that combine lending, leasing, and insurance under one roof, a structure that historically allowed broader product cross-selling than traditional bank holding companies. Its long-standing leasing heritage, dating to its origins in 1964 as one of Japans first leasing firms, continues to anchor the business, while segments such as aircraft leasing, renewable energy, and overseas asset management reflect a strategic shift toward higher-margin, capital-light fee income.

Headlines to Watch Out For
  • BOJ rate hikes expand net interest margins
  • Aircraft leasing income rebounds on global travel recovery
  • US private equity portfolio faces valuation headwinds
Piotroski VR-10 (Strict) 4.5
Net Income: 622b TTM > 0 and > 6% of Revenue
FCF/TA: 0.00 > 0.02 and ΔFCF/TA -6.87 > 1.0
NWC/Revenue: 91.19% < 20% (prev 191.1%; Δ -99.92% < -1%)
CFO/TA 0.08 > 3% & CFO 1370b > Net Income 622b
Net Debt (5340b) to EBITDA (1279b): 4.18 < 3
Current Ratio: 1.68 > 1.5 & < 3
Outstanding Shares: last quarter (1.10b) vs 12m ago -3.08% < -2%
Gross Margin: 35.30% > 18% (prev 42.49%; Δ -7.20% > 0.5%)
Asset Turnover: 19.58% > 50% (prev 17.27%; Δ 2.31% > 0%)
Interest Coverage Ratio: 4.49 > 6 (EBIT TTM 872b / Interest Expense TTM 194b)
Altman Z'' 2.50
A: 0.17 (Total Current Assets 7793b - Total Current Liabilities 4646b) / Total Assets 18256b
B: 0.20 (Retained Earnings 3715b / Total Assets 18256b)
C: 0.05 (EBIT TTM 872b / Avg Total Assets 17628b)
D: 0.35 (Book Value of Equity 4710b / Total Liabilities 13414b)
Altman-Z'' = 2.50 = A
Beneish M -3.15
DSRI: 0.48 (Receivables 3168b/5621b, Revenue 3452b/2935b)
GMI: 1.20 (GM 42.49% / 35.30%)
AQI: 1.00 (AQ_t 0.52 / AQ_t-1 0.52)
SGI: 1.18 (Revenue 3452b / 2935b)
TATA: -0.04 (NI 622b - CFO 1370b) / TA 18256b)
Beneish M = -3.15 (Cap -4..+1) = AA
What is the price of IX shares?

As of October 07, 2026, the stock is trading at USD 37.16 with a total of 446,953 shares traded. Over the past week, the price has changed by -2.80%, over one month by -5.23%, over three months by -6.75% and over the past year by +45.14%.

Current recommended Stop Loss: 36.10 (which is 2.9% or 1.4 ATR below the current price).

Is IX a buy, sell or hold?

Orix Ads has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold IX.

  • StrongBuy: 0
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the IX price?
Analysts Target Price 41.4 11.4%
Orix Ads (IX) - Fundamental Data Overview as of 06 October 2026
Market Cap USD = 38.6b (38.6b USD * 1.0 USD.USD)
Market Cap JPY = 6095b (38.6b USD * 157.88 USD.JPY)
P/E Trailing = 10.3978
P/E Forward = 14.245
P/S = 0.0112
P/B = 1.3586
P/EG = 2.7166
Revenue TTM = 3452b JPY
EBIT TTM = 872b JPY
EBITDA TTM = 1279b JPY
Long Term Debt = 5726b JPY (from longTermDebt, last quarter)
Short Term Debt = 583b JPY (from shortTermDebt, last quarter)
Debt = 6309b JPY (from shortLongTermDebtTotal, last quarter)
Net Debt = 5340b JPY (calculated: Debt 6309b - CCE 969b)
Enterprise Value = 11435b JPY (6095b + Debt 6309b - CCE 969b)
Interest Coverage Ratio = 4.49 (Ebit TTM 872b / Interest Expense TTM 194b)
EV/FCF = 307.9x (Enterprise Value 11435b / FCF TTM 37.1b)
FCF Yield = 0.32% (FCF TTM 37.1b / Enterprise Value 11435b)
FCF Margin = 1.08% (FCF TTM 37.1b / Revenue TTM 3452b)
Net Margin = 18.02% (Net Income TTM 622b / Revenue TTM 3452b)
Gross Margin = 35.30% ((Revenue TTM 3452b - Cost of Revenue TTM 2233b) / Revenue TTM)
Gross Margin QoQ = 44.51% (prev 34.79%)
Tobins Q-Ratio = 0.63 (Enterprise Value 11435b / Total Assets 18256b)
Interest Expense / Debt = 3.08% (Interest Expense 194b / Debt 6309b)
Taxrate = 33.21% (314b / 944b)
NOPAT = 583b (EBIT 872b * (1 - 33.21%))
Current Ratio = 1.68 (Total Current Assets 7793b / Total Current Liabilities 4646b)
Debt / Equity = 1.34 (Debt 6309b / totalStockholderEquity, last quarter 4710b)
Debt / EBITDA = 4.18 (Net Debt 5340b / EBITDA 1279b)
Debt / FCF = 143.8 (Net Debt 5340b / FCF TTM 37.1b)
Total Stockholder Equity = 4560b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.53% (Net Income 622b / Total Assets 18256b)
RoE = 13.64% (Net Income TTM 622b / Total Stockholder Equity 4560b)
RoCE = 8.48% (EBIT 872b / Capital Employed (Equity 4560b + L.T.Debt 5726b))
RoIC = 4.16% (NOPAT 583b / Invested Capital 14021b)
WACC = 5.43% (E(6095b)/V(12404b) * Re(8.93%) + D(6309b)/V(12404b) * Rd(3.08%) * (1-Tc(0.33)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.13 | Cagr: -2.71%
[DCF] Terminal Value 73.10% ; FCFF base≈503b ; Y1≈441b ; Y5≈357b
[DCF] Fair Price = 369.7 (EV 5724b - Net Debt 5340b = Equity 384b / Shares 1.04b; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -89.26 | EPS CAGR: -36.09% | SUE: N/A | # QB: 0
Revenue Correlation: 94.50 | Revenue CAGR: 8.58% | SUE: -0.07 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-12-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2027-03-31): EPS=4.90 | Chg30d=N/A | Revisions=-25% | GrowthEPS=-61.7% | GrowthRev=+382.9%
EPS next Year (2028-03-31): EPS=3.00 | Chg30d=N/A | Revisions=-25% | GrowthEPS=-38.6% | GrowthRev=+5.7%